Benjamin Vipler/LinkedIn
Sep 24, 2026, 06:33
Benjamin Vipler: Optimal Oral Anticoagulation Choice in Atrial Fibrillation and Advanced CKD
Benjamin Vipler, Associate Professor of Medicine at University of Colorado School of Medicine, shared a post on LinkedIn about a recent article by Qiaoxi Chen et al, published in JAMA Network Open, adding:
“These findings suggest that among patients with atrial fibrillation and advanced chronic kidney disease not receiving dialysis, apixaban may be the preferred oral anticoagulant when anticoagulation is considered.”
Title: Oral Anticoagulants in Patients With Atrial Fibrillation and Advanced CKD Not Requiring Dialysis
Authors: Qiaoxi Chen, Daniel E. Singer, Edouard L. Fu, Chun-Ting Yang, Kevin Pritchard, Rishi J. Desai, Kueiyu Joshua Lin
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 9, 2026, 09:29Veronica Sanchez: A Framework for Woman’s Health
-
Nov 8, 2026, 19:31Anna Kajaste-Rudnitski: Presenting AAV-Induced p53 Signalling in Human CNS Cells at ESGCT 26
-
Nov 8, 2026, 19:29David McIntosh: Cybersecurity Matters, but Blood Availability Remains the Bigger Challenge
-
Nov 8, 2026, 19:26Wenxue Ma: An Integrative Framework for Macrophage-Mediated Therapeutic Resistance in Cancer
-
Nov 8, 2026, 19:25Yildiz Yigit: Presenting a Polycythemia Vera Case at the MPN Subcommittee Session
-
Nov 8, 2026, 18:56Denis Oduor: Strengthening the Regulation and Delivery of Blood Transfusion and Transplantation Services
-
Nov 8, 2026, 18:28Raghavendra Rao: A Narrative Review on Chronic Venous Disease during Pregnancy
-
Nov 8, 2026, 17:57Dhiren Patel: PLD1-Derived Phospholipids Regulate NAD Kinase and ROS Production in Neutrophils
-
Nov 8, 2026, 17:48Andra T.: What Causes Antiphospholipid Syndrome? – Four Steps, not One Cause